Terms ending in 2039
Otsuka Pharmaceutical Co., Ltd.
Every in-force patent on Otsuka Pharmaceutical Co., Ltd.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,573,243 | Temperature Control System In force · High confidence | Konica Minolta, Inc. | In force | High confidence | |
| US 11,241,684 | Reaction Method In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,098,067 | Method of 4-Boronophenylalanine Production In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,466,016 | Pharmaceutical Compounds In force · High confidence | Otsuka Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,414,391 | Oxazole Compound Crystal In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,840,512 | Oxazole Compound Crystal In force · Low confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Low confidence | |
| US 12,564,335 | Low Power Receiver for in Vivo Channel Sensing and Ingestible Sensor Detection with Wandering Frequency In force · Medium confidence | Otsuka Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US 12,365,950 | Method of Detecting Conjunctival Disease Using Ocular Surface Tissue, and Aging Biomarker In force · High confidence | Osaka University and Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,630,071 | Analysis Method and Analysis Device In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,408,817 | Detection Chip, Detection System, and Detection Method In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| 4 more term ends in 2039 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
11 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.